Impact of medical interventions on quality of life in cardiovascular disease: a consensus viewpoint.

Jennifer M. Arnold(London Health Sciences Centre), W. Warnica, William R. Black, Susan D. Mathias(Health Outcomes Solutions (United States)), R. F. Tasch, Zion Sasson, Charity J. Morgan(University of Alabama at Birmingham), R MacDonald, Jasjit Gill, Lyall Higginson(University of Ottawa), Eve Smith(University of Liverpool), Victor F. Huckell(University of British Columbia Hospital), Peter Klinke
PubMed
March 1, 1997
Cited by 1

Related Papers

Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women
|JAMA|2002|576
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.
|Circulation|1994|505
High-Dose Epinephrine in Adult Cardiac Arrest
|New England Journal of Medicine|1992|377
Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial
|The Lancet|2001|346
Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study)
|Journal of the American College of Cardiology|2005|254